Recombinant multi-species PAFAH1B3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PAFAH1B3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an acetylhydrolase that catalyzes the removal of an acetyl group from the glycerol backbone of platelet-activating factor. The encoded enzyme is a subunit of the platelet-activating factor acetylhydrolase isoform 1B complex, which consists of the catalytic beta and gamma subunits and the regulatory alpha subunit. This complex functions in brain development. A translocation between this gene on chromosome 19 and the CDC-like kinase 2 gene on chromosome 1 has been observed, and was associated with cognitive disability, ataxia, and atrophy of the brain. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]
The Alternative Names of target: PAF acetylhydrolase 29 kDa subunit (PAF-AH 29 kDa subunit),PAF-AH subunit gamma (PAFAH subunit gamma),PAFAH1B3,PAFAHG,Pafah1b3,Pafahg,Platelet-activating factor acetylhydrolase IB subunit alpha1,mus[g]

Target products collectionGo to PAFAH1B3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9191-Ag-1/ GM-Tg-hg-IP9191-Ag-2 Human PAFAH1B3 protein Human
GM-Tg-rg-IP9191-Ag-1/ GM-Tg-rg-IP9191-Ag-2 Rat PAFAH1B3 protein Rat
GM-Tg-mg-IP9191-Ag-1/ GM-Tg-mg-IP9191-Ag-2 Mouse PAFAH1B3 protein Mouse
GM-Tg-cynog-IP9191-Ag-1/ GM-Tg-cynog-IP9191-Ag-2 Cynomolgus/Rhesus macaque PAFAH1B3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9191-Ag-1/ GM-Tg-felg-IP9191-Ag-2 Feline PAFAH1B3 protein Feline
GM-Tg-cang-IP9191-Ag-1/ GM-Tg-cang-IP9191-Ag-2 Canine PAFAH1B3 protein Canine
GM-Tg-bovg-IP9191-Ag-1/ GM-Tg-bovg-IP9191-Ag-2 Bovine PAFAH1B3 protein Bovine
GM-Tg-equg-IP9191-Ag-1/ GM-Tg-equg-IP9191-Ag-2 Equine PAFAH1B3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9191-Ag-1/ GM-Tg-hg-IP9191-Ag-2; GM-Tg-rg-IP9191-Ag-1/ GM-Tg-rg-IP9191-Ag-2;
GM-Tg-mg-IP9191-Ag-1/ GM-Tg-mg-IP9191-Ag-2; GM-Tg-cynog-IP9191-Ag-1/ GM-Tg-cynog-IP9191-Ag-2;
GM-Tg-felg-IP9191-Ag-1/ GM-Tg-felg-IP9191-Ag-2; GM-Tg-cang-IP9191-Ag-1/ GM-Tg-cang-IP9191-Ag-2;
GM-Tg-bovg-IP9191-Ag-1/ GM-Tg-bovg-IP9191-Ag-2; GM-Tg-equg-IP9191-Ag-1/ GM-Tg-equg-IP9191-Ag-2
Products Name PAFAH1B3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PAFAH1B3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PAFAH1B3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.